← Latest Filings

H

Huizenga Theodore Alan

SVP, Chief Accounting Officer

Open-market buys

0

$0 total

Open-market sells

4

$60K total

Tracking since

Dec 2025

Activity timeline

Open-market sale — $17K

Ultragenyx Pharmaceutical Inc. · Sep 15, 2026

Open-market sale — $2K

Ultragenyx Pharmaceutical Inc. · Sep 3, 2026

Open-market trades from the last two years.

Holdings as last reported

67,863 Common Stock in RARE

Held directly · as of 2026-09-15

7,348 Stock Option (Right to Buy) in RARE

Held directly · as of 2026-04-22

Companies touched

Ultragenyx Pharmaceutical Inc.